BioCryst Pharmaceuticals
BCRX
#4678
Rank
HK$12.24 B
Marketcap
HK$58.61
Share price
-2.20%
Change (1 day)
45.76%
Change (1 year)

P/S ratio for BioCryst Pharmaceuticals (BCRX)

P/S ratio as of March 2025 (TTM): 3.82

According to BioCryst Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -3.31. At the end of 2024 the company had a P/S ratio of 3.82.

P/S ratio history for BioCryst Pharmaceuticals from 2001 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20243.823.22%
20233.70-53.16%
20227.90-50.16%
202115.9-78.53%
202073.8578.44%
201910.9-74.69%
201843.0124.18%
201719.28.28%
201617.712.94%
201515.7-75.6%
201464.3148.13%
201325.9842.78%
20122.75-51.66%
20115.6952.58%
20103.73-2.01%
20093.80310.36%
20080.9267-71.87%
20073.29-93.95%
200654.4-98.29%
2005> 1000-77.51%
2004> 100018759.03%
200374.9684.31%
20029.5552.86%
20016.25

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
12.8 235.63%๐Ÿ‡บ๐Ÿ‡ธ USA
5.82 52.38%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
1.55-59.38%๐Ÿ‡บ๐Ÿ‡ธ USA
4.99 30.63%๐Ÿ‡บ๐Ÿ‡ธ USA
134 3,409.45%๐Ÿ‡บ๐Ÿ‡ธ USA
1.99-48.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
0.2736-92.83%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA